Last reviewed · How we verify
Endometrial carcinoma progressing after chemotherapy
Approved treatments
- Lenvima · Eisai
Lenvima works by blocking the activity of a specific protein called Ret, which is involved in the growth and spread of cancer cells. - Pembrolizuma · Memorial Sloan Kettering Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Endometrial carcinoma progressing after chemotherapy patent landscape — cliff calendar, originator estates, attackable patents
- Endometrial carcinoma progressing after chemotherapy treatment landscape brief
- Endometrial carcinoma progressing after chemotherapy treatment updates RSS
Frequently asked questions about Endometrial carcinoma progressing after chemotherapy
What drugs treat Endometrial carcinoma progressing after chemotherapy?
Tracked treatments include Lenvima, Pembrolizuma.
What is the treatment for Endometrial carcinoma progressing after chemotherapy?
Standard treatment for Endometrial carcinoma progressing after chemotherapy includes Lenvima, Pembrolizuma. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Endometrial carcinoma progressing after chemotherapy patent cliff · Endometrial carcinoma progressing after chemotherapy CI report
- Treatment: Lenvima · Eisai
- Treatment: Pembrolizuma · Memorial Sloan Kettering Cancer Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing